METROPOLITAN LIFE INSURANCE CO/NY - APPLIED MOLECULAR TRANS INC ownership

APPLIED MOLECULAR TRANS INC's ticker is AMTI and the CUSIP is 03824M109. A total of 82 filers reported holding APPLIED MOLECULAR TRANS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of APPLIED MOLECULAR TRANS INC
ValueSharesWeighting
Q4 2021$92,058
-46.0%
6,5850.0%0.00%
-50.0%
Q3 2021$170,354
-43.4%
6,5850.0%0.00%
-50.0%
Q2 2021$301,198
+9.2%
6,585
+5.1%
0.00%0.0%
Q1 2021$275,723
+132.5%
6,265
+62.6%
0.00%
+100.0%
Q4 2020$118,588
-3.3%
3,8540.0%0.00%0.0%
Q3 2020$122,6343,8540.00%
Other shareholders
APPLIED MOLECULAR TRANS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Founders Fund V Management, LLC 3,611,615$165,195,00056.39%
EPIQ Capital Group, LLC 8,764,720$400,899,00041.88%
PACIFIC HEIGHTS ASSET MANAGEMENT LLC 175,000$8,004,0000.73%
Burleson & Company, LLC 106,277$4,861,0000.71%
Virtus ETF Advisers LLC 4,565$209,0000.09%
Maven Securities LTD 34,191$1,569,0000.06%
Woodline Partners LP 50,600$2,314,0000.04%
Capital Research Global Investors 3,930,356$179,774,0000.04%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 40,500$1,852,0000.03%
Capital World Investors 4,197,918$192,013,0000.03%
View complete list of APPLIED MOLECULAR TRANS INC shareholders